Sienna Cancer Diagnostics Ltd. announced the appointment of Aenorasis S. A as its exclusive distributor in Greece and Cyprus. The distribution agreement provides Aenorasis with the right to sell Sienna's hTERT IVD to pathology laboratories where it will be used to assist in the diagnosis of bladder cancer. Aenorasis is also an exclusive distributor for Hologic's ThinPrep® liquid-based cytology products. These products are the upstream component of Sienna's hTERT test, making the partnership between Sienna and Aenorasis a perfect fit for both companies. Sienna will soon begin sales and technical training with Aenorasis staff, in addition to setting up two reference laboratories in Greece. Aenorasis is Sienna's fifth distributor appointment in 2020 as the Company continues its overseas expansion.